<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"
                xmlns:wfw="http://wellformedweb.org/CommentAPI/"
                xmlns:dc="http://purl.org/dc/elements/1.1/"
                xmlns:sy="http://purl.org/rss/1.0/modules/syndication/">
<channel>
<title>Ambry Genetics News by Category: Breast Cancer</title>
<link>https://blog.ambrygen.com/list/category/Breast%20Cancer</link>
<description>Find the latest Ambry Genetics news by category: Breast Cancer</description>
<language>en</language>
<image>
<title>Ambry Genetics Blog</title>
<link>https://blog.ambrygen.com/list/category/Breast%20Cancer</link>
<url>https://blog.ambrygen.com/assets/img/logo/Ambry_logo_web.jpg</url>
</image>
<item>
<title>Leading the Shift to Proactive Care: The Christ Hospital’s High‑Risk Program Strategy</title>
<link>https://blog.ambrygen.com/ambry/post/435/leading-the-shift-to-proactive-care-the-christ-hospitals-high-risk-program-strategy</link>
<description>The Christ Hospital Health Network is turning to proactive population health strategy with The CARE Program to identify more at-risk patients for hereditary cancer risks.</description>
<pubDate>Thu, 16 Apr 26 06:45:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Breast Cancer</category>
</item>
<item>
<title>A Hidden Cancer, Found in Time: One Patient’s CARE Journey</title>
<link>https://blog.ambrygen.com/ambry/post/436/a-hidden-cancer-found-in-time-one-patients-care-journey</link>
<description>Danielle Rogers discusses the case study of a patient with RET, her genetic testing, and personalized screening journey.</description>
<pubDate>Thu, 09 Apr 26 08:12:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Breast Cancer</category>
</item>
<item>
<title>The CARE Difference: A Smarter Workflow for High‑Risk Screening</title>
<link>https://blog.ambrygen.com/ambry/post/431/the-care-difference-a-smarter-workflow-for-high-risk-screening</link>
<description>Danielle Rogers, oncology and genetics nurse practitioner, recently shared her experience with providing personalized assessments of cancer risks before and after implementation of the Ambry CARE Program® (CARE).</description>
<pubDate>Wed, 25 Mar 26 06:00:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Breast Cancer</category>
</item>
<item>
<title>Making Waves with MAVES</title>
<link>https://blog.ambrygen.com/ambry/post/424/making-waves-with-maves</link>
<description>Discover how a BRCA2 variant reclassification, thanks in part to new MAVEs data and the Ambry Classifi® Program, unlocked potentially life-saving options for a 2x breast cancer survivor.</description>
<pubDate>Wed, 11 Mar 26 07:48:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Breast Cancer</category>
</item>
<item>
<title>The Gene Scene: PALB2</title>
<link>https://blog.ambrygen.com/ambry/post/405/the-gene-scene-palb2</link>
<description>The Gene Scene covers PALB2 and its association with prostate, breast, ovarian and other cancers and genetic predisposition to other conditions.</description>
<pubDate>Tue, 04 Nov 25 05:50:00 -0800</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Breast Cancer</category>
</item>
<item>
<title>Progeny Research Spotlight: Uncovering Breast Cancer Risk in the GYN Oncology Clinic</title>
<link>https://blog.ambrygen.com/ambry/post/401/progeny-research-spotlight-uncovering-breast-cancer-risk-in-the-gyn-oncology-clinic</link>
<description>Dr. Melissa Frey applies breast cancer risk models from Progeny and discovers a significant number were also at elevated risk for breast cancer.</description>
<pubDate>Wed, 22 Oct 25 05:49:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Breast Cancer</category>
</item>
<item>
<title>Unlocking Personalized Breast Care: The Role of Breast Density</title>
<link>https://blog.ambrygen.com/ambry/post/398/unlocking-personalized-breast-care-the-role-of-breast-density</link>
<description>Combining annual breast density monitoring with a validated, evolving risk model like Tyrer-Cuzick offers the most accurate roadmap for personalized screening and early detection.</description>
<pubDate>Wed, 24 Sep 25 07:13:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Breast Cancer</category>
</item>
<item>
<title>Creating Program Champions: The Power of Staff Education and Ownership in Our High-Risk Women's Program</title>
<link>https://blog.ambrygen.com/ambry/post/381/creating-program-champions-the-power-of-staff-education-and-ownership-in-our-high-risk-womens-program</link>
<description>Lisa McGuire discusses the importance of the Ambry CARE Program in launching a High-Risk Women's Program at HCA Florida Ocala</description>
<pubDate>Wed, 16 Jul 25 06:11:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Breast Cancer</category>
</item>
<item>
<title>Building Trust in Digital Screening: Validating CARE’s Hereditary Cancer Risk Assessment</title>
<link>https://blog.ambrygen.com/ambry/post/376/building-trust-in-digital-screening-validating-cares-hereditary-cancer-risk-assessment</link>
<description>Rob Pilarski shares validation results for Ambry's CARE Program® (CARE), recently published in the Journal of the National Comprehensive Cancer Network.</description>
<pubDate>Thu, 26 Jun 25 07:17:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Breast Cancer</category>
</item>
<item>
<title>Personalized Care in Action: The Unexpected Discovery That Validated Our High-Risk Program</title>
<link>https://blog.ambrygen.com/ambry/post/378/personalized-care-in-action-the-unexpected-discovery-that-validated-our-high-risk-program</link>
<description>Lisa McGuire shares how a combination of innovative technology and dedicated healthcare teams can transform patient outcomes.</description>
<pubDate>Wed, 04 Jun 25 06:09:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Breast Cancer</category>
</item>
<item>
<title>From Fear to Empowerment: A Patient's Perspective on the Ambry CARE Program</title>
<link>https://blog.ambrygen.com/ambry/post/360/from-fear-to-empowerment-a-patients-perspective-on-the-ambry-care-program</link>
<description>The Ambry CARE Program® helps providers identify high-risk patients, offers genetic testing and genetic counseling at scale, and gives patients insights to help them better manage their health. This blog looks at CARE from the patient’s perspective.</description>
<pubDate>Wed, 15 Jan 25 06:36:00 -0800</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Breast Cancer</category>
</item>
<item>
<title>Early Detection in Action: Angie’s CARE Story</title>
<link>https://blog.ambrygen.com/ambry/post/365/early-detection-in-action-angies-care-story</link>
<description>One CARE patient’s story demonstrates the power of proactive care and comprehensive high-risk screening.</description>
<pubDate>Thu, 31 Oct 24 05:43:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Breast Cancer</category>
</item>
<item>
<title>Expanding Your High-Risk Breast Program: Best Practices for Growth and Impact</title>
<link>https://blog.ambrygen.com/ambry/post/356/expanding-your-high-risk-breast-program-best-practices-for-growth-and-impact</link>
<description>Nurse Adrianne Alexander shares practical, engaging, and impactful best practices to expand a high-risk breast program.</description>
<pubDate>Wed, 17 Jul 24 05:36:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Breast Cancer</category>
</item>
<item>
<title>From Vision to Reality: Best Practices for Building High-Risk Breast Programs</title>
<link>https://blog.ambrygen.com/ambry/post/354/from-vision-to-reality-best-practices-for-building-high-risk-breast-programs</link>
<description>A high-risk breast program is designed to identify patients with an elevated risk of developing breast cancer and then offering genetic counseling, genetic testing, additional breast imaging, and risk-reduction strategies to mitigate their cancer risks.</description>
<pubDate>Thu, 20 Jun 24 06:41:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Breast Cancer</category>
</item>
<item>
<title>Putting Patients First: The Ambry CARE Program®'s Commitment to Patient Experience</title>
<link>https://blog.ambrygen.com/ambry/post/348/putting-patients-first-the-ambry-care-program-r-s-commitment-to-patient-experience</link>
<description>Heather Fecteau explains how since the launch of the Ambry CARE Program® in 2019, Ambry has also consistently helped to improve the delivery of genetic services.</description>
<pubDate>Wed, 01 May 24 07:26:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Breast Cancer</category>
</item>
<item>
<title>Empowering Patient-Centric Breast Care: How The Ambry CARE Program™ Provides Evolving, Personalized Risk Assessment</title>
<link>https://blog.ambrygen.com/ambry/post/341/empowering-patient-centric-breast-care-how-the-ambry-care-programtm-provides-evolving-personalized-risk-assessment</link>
<description>Discusses the average risk of breast cancer versus a patient's personal risk, factors that contribute and how The Ambry CARE Program addresses these risks for personalized, proactive care.</description>
<pubDate>Wed, 20 Mar 24 03:46:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Breast Cancer</category>
</item>
<item>
<title>Variant Interpretation in Real Time: Sometimes it Takes a Village</title>
<link>https://blog.ambrygen.com/ambry/post/337/variant-interpretation-in-real-time-sometimes-it-takes-a-village</link>
<description>Genetic counselors explain how a CDH1 variant was classified as likely pathogenic from VUS status.</description>
<pubDate>Fri, 23 Feb 24 08:36:00 -0800</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Breast Cancer</category>
</item>
<item>
<title>CARE Patient Examples at Lake Health</title>
<link>https://blog.ambrygen.com/ambry/post/331/care-patient-examples-at-lake-health</link>
<description>Dr. Liese Vito shares examples of hereditary cancer testing at Lake Health for patients with a BRCA+ and PMS2 mutation and the preventative healthcare measures they were able to take.</description>
<pubDate>Wed, 07 Feb 24 03:39:00 -0800</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Breast Cancer</category>
</item>
<item>
<title>Hereditary Cancer Testing with CARE</title>
<link>https://blog.ambrygen.com/ambry/post/330/hereditary-cancer-testing-with-care</link>
<description>Dr. Liese Vito describes the CARE Program at Lake Health and how it was able to help them offer hereditary cancer screening and genetic testing to more patients.</description>
<pubDate>Wed, 24 Jan 24 03:20:00 -0800</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Breast Cancer</category>
</item>
<item>
<title>Off My Chest: How Negative Genetic Testing and a Supportive Community Helped Me Navigate Breast Cancer</title>
<link>https://blog.ambrygen.com/ambry/post/323/off-my-chest-how-negative-genetic-testing-and-a-supportive-community-helped-me-navigate-breast-cancer</link>
<description>Kristina O'Quinn shares her experience as a breast cancer survivor who underwent genetic testing to help inform her mastectomy choices.</description>
<pubDate>Wed, 25 Oct 23 10:00:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Breast Cancer</category>
</item>
<item>
<title>Understanding Gene-Disease Validity in Breast Cancer: The Power of Evidence</title>
<link>https://blog.ambrygen.com/ambry/post/322/understanding-gene-disease-validity-in-breast-cancer-the-power-of-evidence</link>
<description>An overview of gene-disease validity in the context of breast cancer, which affects approximately 1 in every 8 women.</description>
<pubDate>Tue, 17 Oct 23 04:07:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Breast Cancer</category>
</item>
<item>
<title>Her Healthcare: Leveraging the CARE Program to Scale High-Risk Patient Identification</title>
<link>https://blog.ambrygen.com/ambry/post/317/her-healthcare-leveraging-the-care-program-to-scale-high-risk-patient-identification</link>
<description>Dr. Boyd, patient Kristi and medical assistant Briana Guro give their thoughts on the implementation of The CARE Program in their practice.</description>
<pubDate>Wed, 09 Aug 23 07:38:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Breast Cancer</category>
</item>
<item>
<title>Her Healthcare: Offering Comprehensive Care with Hereditary Cancer Testing</title>
<link>https://blog.ambrygen.com/ambry/post/316/her-healthcare-offering-comprehensive-care-with-hereditary-cancer-testing</link>
<description>Dr. Noel Boyd from Her Healthcare in Houston, TX, explains the importance of genetic testing for hereditary cancer risk,</description>
<pubDate>Wed, 02 Aug 23 06:00:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Breast Cancer</category>
</item>
<item>
<title>Outlier: Runi Limary Let Her Voice Be Heard on BRCA Gene Patents</title>
<link>https://blog.ambrygen.com/ambry/post/311/outlier-runi-limary-let-her-voice-be-heard-on-brca-gene-patents</link>
<description>Runi Limary gave her testimony as a patient in the court case regarding BRCA1 and BRCA2. She shared her thoughts on the experience, her breast cancer diagnosis and observations from her work.</description>
<pubDate>Tue, 13 Jun 23 03:00:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Breast Cancer</category>
</item>
<item>
<title>Ambry Genetics Diagnostic Dilemma: +RNAinsight® Reveals Lynch Syndrome in Sisters</title>
<link>https://blog.ambrygen.com/ambry/post/306/ambry-genetics-diagnostic-dilemma-rnainsight-r-reveals-lynch-syndrome-in-sisters</link>
<description>In recognition of Colon Cancer Awareness Month, Ambry shares the story of Jane and Julie Smith – sisters and cancer survivors – who used RNAInsight to determine they had Lynch syndrome.</description>
<pubDate>Thu, 23 Mar 23 00:06:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Breast Cancer</category>
</item>
</channel>
</rss>
